Abstract
We made a bibliographic search for Japanese and non-Japanese literature on tuberculosis control programs to study the current public health policies for tuberculosis control in Japan especially in regard to cost-effectiveness. Then, we compared the Japanese, strategies for tuberculosis control with those in other countries including the United States, and those recommended by World Health Organization (WHO). The current trend of tuberculosis incidence in the Japanese community demonstrates major differences from the situation that had prompted installation of tuberculosis control measures several decades ago. The tuberculosis control measures should be targeted to the elderly people (over 65 years old) because of the following three aspects. (1) A continuing decline of tuberculosis in the young Japanese population, particularly children who might attain benefits from BCG immunization; (2) The enhancement of the prevalence among the elderly people who are not covered by a uniform national surveillance strategy; (3) Cost-ineffectiveness of Mass Miniature Radiography (MMR) being used as a means to screen for tuberculosis. The cost-effectiveness issue must be considered more seriously, and the WHO recommendations especially in regard with the DOTS (directly-observed treatment, short course) strategy need to be incorporated more effectively into the national program since the incidence of drug resistant tuberculosis in Japan has been recently increasing. Finally, we propose to limit BCG immunization further and to discontinue annual MMR in the young population, and instead to develop effective strategies of both active and passive case finding in the elderly through public and community health services.
Key words: active case-finding (AFC), BCG immunization, mass miniature radiography (MMR), sputum smear examination, tuberculosis (TB)
References
- (1).Kistemann T, Munzinger A, Dangendorf F. Spatial patterns of tuberculosis incidence in Cologne (Germany). Soc Sci Med. 2002; 55: 7–19. [DOI] [PubMed]
- (2).Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991; 144: 745–749. [DOI] [PubMed]
- (3).The World Health Organization (WHO). Guidelines for cost and cost-effectiveness analysis of tuberculosis control; Document 1: Introduction, important economic concepts, protocols and useful references. Geneva: World Health Organization Publications; 2002.
- (4).Rahman M, Sekimoto M, Hira K, Koyama H, Imanaka Y, Fukui T. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children? Prev Med. 2002; 35: 70–77. [DOI] [PubMed]
- (5).Mori T. Recent trends in tuberculosis, Japan. Emerg Infect Dis. 2000; 6: 566–568. [DOI] [PMC free article] [PubMed]
- (6).Rahman M, Sekimoto M, Takamatsu I, Hira K, Shimbo T, Toyoshima K, Fukui T. Economic evaluation of universal BCG vaccination of Japanese infants. Int J Epidemiol. 2001; 30: 380–385. [DOI] [PubMed]
- (7).Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA. 1994; 271: 698–702. [DOI] [PubMed]
- (8).Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993; 22: 1154–1158. [DOI] [PubMed]
- (9).Smith PG. Case-control studies of the efficacy of BCG against tuberculosis. In: International Union Against Tuberculosis editors. Proceedings of the XXVIth IUATLD World Conference on Tuberculosis and Respiratory Diseases. Singapore: Professional Postgraduate Services International; 1987. p. 73–79.
- (10).The World Health Organization (WHO). Global tuberculosis program and global program on vaccines: Statement on BCG revaccination for prevention of tuberculosis. WHO Wkly Epidem Rec. 1995; 70: 229–236. [PubMed]
- (11).Leung CC, Tam CM, Chan SL, Chan MMW, Chan CK, Chang KC. Efficacy of the BCG revaccination program in a cohort given BCG vaccination at birth in Hong Kong. Int J Tubere Lung Dis. 2001; 5: 717–723. [PubMed]
- (12).Tam CM, Leung CC. Cessation of the BCG (bacilli Calmette Guerin): Revaccination program for primary school children in Hong Kong. Public Health & Epidemiology Bulletin. 2000; 9: 25–27
- (13).Ballew KA, Becker DM. Tuberculosis screening in adults who have received bacille Calmette-Guerin vaccine. South Med J. 1995; 88: 1025–1030. [DOI] [PubMed]
- (14).Schwartzman K, Menzies D. Tuberculosis sereening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med. 2000; 161: 780–789. [DOI] [PubMed]
- (15).Lotte A, Wasz-Hockert O, Poisson N, et al. BCG complications. Adv Tubere Res. 1984; 21: 107–193. [PubMed]
- (16).Kekkaku No Toukei (Statisties of TB). Shiryo Hyo 6 (Table 6). Kiyose/Tokyo. The Research Institute of Tuberculosis (J.A.T.A.): 2004. p. 27. (in Japanese)
- (17).Kekkaku No Toukei (Statisties of TB). Shiryo Hyo 13 (Table 13). Kiyose/Tokyo, The Research Institute of Tuberculosis (J.A.T.A.): 2004. p. 31. (in Japanese)
- (18).Ohmori M, Wada M, Uchimura K, Nishii K, Shirai Y, Aoki M. Discussing the current situation of tuberculosis case finding by mass miniature radiography in Japan. Kekkaku. 2002; 77: 4329–4339. [PubMed]
- (19).Heldal E, Döcker H, Tverdal A. Previous Tuberculosis Disease or Infection in Norwegian-born Patients with Pulmonary Tuberculosis, 1975, 1985, 1995. National Health Sereening Service. Ministry of Health. Oslo. Norway.
- (20).Pang SC. Chest radiography and tuberculosis case-finding in Western Australia. Respir Med. 1998; 92: 198–202. [DOI] [PubMed]
- (21).Kimerling ME, Schuchter J, Chanthol E, Kunthy T, Stuer F, Glaziou P, Ee O. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia: Int J Tuberc Lung Dis. 2002; 6: 988–994. [PubMed]
- (22).Harries AD, Kamenya A, Subramanyam VR, Maher D, Squire SB, Wirima JJ, Nyangulu DS, Nunn P. Sereening pulmonary tuberculosis suspects in Malawi: testing different strategies. Trans R Soc Trop Med Hyg. 1997; 91: 416–419. [DOI] [PubMed]
- (23).Aluoch JA, Edwards EA, Stott H, Fox W, Sutherland I. A fourth study of case-finding methods for pulmonary tuberculosis in Kenya. Trans R Soc Trop Med Hyg. 1982; 76: 679–691. [DOI] [PubMed]
- (24).Harries AD, Mphasa NB, Mundy C, Banerjee A, Kwanjana JH, Salaniponi FM. Sereening tuberculosis suspects using two sputum smears. Int J Tubere Lung Dis. 2000; 4: 36–40. [PubMed]
- (25).Yamamura J, Sawada T. A study on patients with tuberculosis among foreigners overstayed in Japan after expiration of visa—activities over three years. Kekkaku. 2002; 77: 671–677. [PubMed]
- (26).Mallet L, Strozyk WR. Tuberculosis in the elderly: incidence, manifestations, PPD skin tests, and preventive therapy. DICP, 1991; 25: 650–655. [DOI] [PubMed]
- (27).Falchook G, Gaffga C, Eve S, Ali J. Tuberculosis sereening, referral, and treatment in an inner city homeless shelter in Orleans parish. J La State Med Soc. 2000; 152: 398–404. [PubMed]
- (28).Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D. Comparison of cost-effectiveness of tuberculosis sereening of close contacts and foreign-born populations. Am J Respir Crit Care Med. 2000; 162: 2079–2086. [DOI] [PubMed]
- (29).Mori T. Current tuberculosis problem in Japan and its control. Intern Med. 2002; 41: 56–57. [DOI] [PubMed]